Login
$TRAW
$0.34 -$0.00 (0.41%) Close

$TRAW 3 SEC Filings

Filed On Filing
08 Apr 2026 Form 3: Parker Charles Nolan, Chief Financial Officer

No securities owned

14 Oct 2025 Form 3: Leaman John Harold, Director

No securities owned

07 Feb 2025 Form 3: Brennan Nora, Interim CFO

No securities owned

23 Sep 2024 Form 3: Orbimed Advisors Llc, 10% owner and 1 other

Holds 602,000 shares of Common Stock

17 Sep 2024 Form 3: Greenwood Luba, Director

No securities owned

03 Apr 2024 Form 3: Cautreels Werner, Director

No securities owned

03 Apr 2024 Form 3: Savchuk Nikolay, Director

No securities owned

03 Apr 2024 Form 3: Dukes Iain D., Director

No securities owned

03 Apr 2024 Form 3: TPAV, Llc, 10% owner

Holds 885,532 shares of Common Stock

03 Apr 2024 Form 3: Viriom, Inc., 10% owner

Holds 1,645,100 shares of Common Stock

03 Apr 2024 Form 3: Orbimed Advisors Llc, 10% owner and 1 other

Holds 885,532 shares of Common Stock

03 Apr 2024 Form 3: Redfield Robert, Acting Chief Medical Officer

No securities owned

03 Apr 2024 Form 3: Pauza Charles David, Chief Science Officer Virology

No securities owned

27 Oct 2023 Form 3: Moyo Victor M, CHIEF MEDICAL OFFICER

No securities owned

19 Dec 2022 Form 3: Clarke Trafford, Director

No securities owned

19 Dec 2022 Form 3: Atadja Peter, Director

No securities owned

17 Jun 2021 Form 3: Gelder Mark S. Md, Chief Medical Officer

No securities owned

08 Jun 2020 Form 3: Shoemaker Mary Teresa, Director

No securities owned

25 Sep 2019 Form 3: Armistice CAPITAL, Llc, 10% owner and 2 others

Holds 826,951 shares of Common Stock, par value $0.01 per share

14 Dec 2018 Form 3: Oler Abraham N., VP Corp Dev & Gen Counsel

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support